TB-500 is a synthetic analog of Thymosin Beta-4, studied for its role in actin dynamics and cellular migration
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
Slow-Wave Sleep It is also being researched for its influence on slow-wave sleep, the deepest phase of non-REM sleep
Early access
Researchers hypothesized that blocking NNMT activity could represent a novel therapeutic approach, and 5amino1mq emerged as a major outcome of this effort
Kenneth McCall, published a paper in 2025 finding that compounded GLP-1s were linked to higher rates of adverse effects than non-compounded products between 2018 and 2024, including more abdominal pain, diarrhea, and nausea